Author

Frédéric Dezoteux

Observed names: Dezoteux, F., F DEZOTEUX, F Dezoteux, F. Dezoteux, Frederic Dezoteux, Fréderic Dezoteux, Frédéric, Dezoteux

Institutions: Inserm, Université de Lille, University Hospital Southampton NHS Foundation Trust, Centre Hospitalier Universitaire de Lille, Lille Inflammation Research International Center, Hôpital Claude Huriez, University of Southampton, Institute for Translational Research in Inflammation

Observed institutions: Inserm, Université de Lille, Institut Pasteur de Lille, University Hospital Southampton NHS Foundation Trust, Centre Hospitalier Universitaire de Lille, Centre Hospitalier Universitaire Henri-Mondor, Centre Hospitalier de Douai, Assistance Publique – Hôpitaux de Paris, Lille Inflammation Research International Center, Hôpitaux Universitaires Henri-Mondor, Hôpital Claude Huriez, University of Southampton, Institute for Translational Research in Inflammation

ORCID: 0000-0001-8930-1042

Observed ORCID: 0000-0001-8930-1042

OpenAlex ID: A5041554015

“Idiopathic Eosinophilic Vasculitis”: Another Side of Hypereosinophilic Syndrome? A Comprehensive Analysis of 117 Cases in Asthma-Free Patients

2019 · Guillaume Lefèvre, Amélie Leurs, et al. · The Journal of Allergy and Clinical Immunology In Practice · 58

PDF

DRESS and AGEP Reactions to Iodinated Contrast Media: A French Case Series

2021 · Angèle Soria, Emmanuelle Amsler, et al. · The Journal of Allergy and Clinical Immunology In Practice · 43

PDF

C-Reactive protein as a diagnostic tool in differential diagnosis of hypereosinophilic syndrome and antineutrophil cytoplasmic antibody–negative eosinophilic granulomatosis with polyangiitis

2018 · Amélie Leurs, Cécile Chenivesse, et al. · The Journal of Allergy and Clinical Immunology In Practice · 36

PDF

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Series of 49 French Pediatric Cases

2021 · Eve Bedouelle, Benoit Ben Said, et al. · The Journal of Allergy and Clinical Immunology In Practice · 35

PDF

Multicenter prospective observational study of dupilumab‐induced ocular events in atopic dermatitis patients

2023 · Ingrid Costedoat, Martin Wallaert, et al. · Journal of the European Academy of Dermatology and Venereology · 29

Hypereosinophilia and Hypereosinophilic Syndromes: First Findings From a Nationwide Multicenter Cohort

2025 · Guillaume Lefèvre, Séverine Bleuse, et al. · Allergy · 24

PDF

Skin Testing and Drug Provocation Tests in Epidermal Necrolysis: A French Experience

2022 · Camille Roux, Benoit Ben Said, et al. · The Journal of Allergy and Clinical Immunology In Practice · 24

Severe blistering eruptions induced by immune checkpoint inhibitors: a multicentre international study of 32 cases

2022 · Saskia Ingen-Housz-Oro, Brigitte Milpied, et al. · Melanoma Research · 23

Outcome of early stage Merkel carcinoma treated by exclusive radiation: a study of 53 patients

2021 · Manon Dubois, Henry Abi Rached, et al. · Radiation Oncology · 19

PDF

Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort

2022 · Julia Vanlerberghe, Frédéric Dezoteux, et al. · Journal of the American Academy of Dermatology · 18

PDF

Immune Checkpoint Inhibitor–Induced Vitiligo-Like Depigmentation

2024 · Michela Starace, Stephano Cedirian, et al. · JAMA Dermatology · 16

Retrospective study on the association of human herpesvirus reactivation with severe DRESS : A description of blood and skin reactivations

2023 · C. Marcombes, S. Ingen‐Housz‐Oro, et al. · Journal of the European Academy of Dermatology and Venereology · 16

PDF

French national protocol for diagnosis and management of epidermal necrolysis in adults (Stevens-Johnson syndrome and toxic epidermal necrolysis)

2024 · S. Ingen-Housz-Oro, I. Matei, et al. · Annales de Dermatologie et de Vénéréologie · 14

Omalizumab Drug Survival in Chronic Urticaria: A Retrospective Multicentric French Study

2023 · Julie Litovsky, Florence Hacard, et al. · The Journal of Allergy and Clinical Immunology In Practice · 12

Omalizumab in chronic inducible urticaria: A retrospective, real-life study

2021 · M. Fialek, F. Dezoteux, et al. · Annales de Dermatologie et de Vénéréologie · 11

Characterization of omalizumab updosing patterns and predictive factors in chronic spontaneous urticaria: A prospective multicentric observational study

2024 · Guillaume Pierrard, Claire Bernier, et al. · Allergy · 10

PDF

Atopic dermatitis in elderly adults

2019 · Frédéric Dezoteux, Bellissen Astrid, et al. · European Journal of Dermatology · 10

PDF

Cutaneous manifestations following COVID‐19 vaccination: a multicentric descriptive cohort

2021 · E. Massip, P. Marcant, et al. · Journal of the European Academy of Dermatology and Venereology · 8

PDF

Endocardite à Bacillus cereus avec probable porte d’entrée cutanée

2016 · S. Soudet, C. Becquart, et al. · Annales de Dermatologie et de Vénéréologie · 7

Enhanced Siglec-8 and HLA-DR and reduced CRTH2 surface expression highlight a distinct phenotypic signature of circulating eosinophils in atopic dermatitis

2025 · Frédéric Dezoteux, Pierre Marcant, et al. · Journal of Leukocyte Biology · 6

Automatic quantification method of eosinophilic degranulation in tissues: Application for the study of eosinophilic disorders

2023 · Frédéric Dezoteux, Antonino Bongiovanni, et al. · Clinical & Experimental Allergy · 6

PDF

Real-life use of apremilast for the treatment of psoriasis in patients with oncological comorbidities: a retrospective descriptive multicentre study in France

2023 · Pauline Podevin, Anne-Caroline Cottencin, et al. · European Journal of Dermatology · 6

Interactions between eosinophils and IL-5Rα–positive mast cells in nonadvanced systemic mastocytosis

2024 · Guillaume Lefèvre, Jean-Baptiste Gibier, et al. · Journal of Allergy and Clinical Immunology · 5

PDF

Efficacy and tolerance of dupilumab in patients with moderate‐to‐severe atopic dermatitis and obesity

2024 · Joséphine Dupuis, Marie Tauber, et al. · Journal of the European Academy of Dermatology and Venereology · 5

Herpes Zoster Following a Nucleoside-Modified Messenger RNA COVID-19 Vaccine

2022 · Frédéric Dezoteux · Cutis · 5

PDF

Works count: 147

Citation count: 528

H-index: 13

I10-index: 17